Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRVI | MLYS |
|---|---|---|
| Price | $13.72 | $23.30 |
| Change today | ▼ 1.37% | ▼ 1.40% |
| Market cap | $1.95B | $2.06B |
| Return, 3 months | -29.6% | -23.5% |
| Return, year to date | +9.6% | -35.8% |
| Return, 1 year | +37.9% | -38.7% |
| P/E (TTM) | -39.2 | -5.5 |
| P/B | 6.1 | 3.7 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | +13.0% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +111.4% | +118.9% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 25 | 34 |
| 30-day volatility | 35.1% | 67.5% |
| Max drawdown, 1 year | -29.6% | -52.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
